Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Precision Biosciences (DTIL) over the last 6 years, with Q3 2025 value amounting to $10.0 million.

  • Precision Biosciences' Other Non-Current Liabilities fell 573.15% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year decrease of 573.15%. This contributed to the annual value of $10.0 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Precision Biosciences reported Other Non-Current Liabilities of $10.0 million as of Q3 2025, which was down 573.15% from $10.0 million recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Other Non-Current Liabilities ranged from a high of $22.0 million in Q1 2024 and a low of $392000.0 during Q1 2021
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $10.0 million (2021), whereas its average is $10.4 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first soared by 245102.04% in 2021, then crashed by 5458.67% in 2025.
  • Over the past 5 years, Precision Biosciences' Other Non-Current Liabilities (Quarter) stood at $10.0 million in 2021, then changed by 0.0% to $10.0 million in 2022, then changed by 0.0% to $10.0 million in 2023, then changed by 0.0% to $10.0 million in 2024, then changed by 0.0% to $10.0 million in 2025.
  • Its Other Non-Current Liabilities stands at $10.0 million for Q3 2025, versus $10.0 million for Q2 2025 and $10.0 million for Q1 2025.